Convergent synthesis and SAR of dolastatin 15 by solid phase coupling

固相偶联聚合合成多拉司他汀15及比吸收率

基本信息

项目摘要

Dolastatin 15 is a cytostatic depsipeptide isolated from the marine mollusk Dolabella auricularia by Pettit et. al. in 1989. Among the dolastatins, an unprecedented series of linear and cyclic antineoplastic and/or cytostatic peptide isolated from the Indian Ocean sea hare, dolastatin 15 as well as dolastatin 10 represent the two most important members because of the strong and selective activities.For completing the synthesis of dolastatin 15, single step segment condensation between peptide fragment and nonpeptide fragment by the CIP/HOAt method was used, since activation at the Pro residue is resistance to isomerization. N, N-dimethylamino acid was incorporated in peptide fragment 2 since CIP-mediated activation is expected to be efficient enough for hindered couplings in solution. Pro, 2-hydroxyisovaleric acid (Hiva), and Phe was employed for the preparation of nonpeptide fragment. The Pyrrolidone ring of was constructed by the CIP-mediated coupling of Phe and Meldrum's ester employed as C2 unit. For the preparation of peptide fragment, CIP-mediated activation for the coupling of N-methylamino acid on solid support was selected as a preferable scheme to facilitate the practical synthesis of dolastatin 15. Thus, prior to the synthesis of dolastatin 15 according to the scheme, we evaluated CIP-mediated activation for its efficiency in preparing peptide sequence containing N-methylamino acids on solid support.In conclusion, a convergent synthesis utilizing single step condensation of fragment and pyrrolidone fragment using CIP-HOAt as an efficient coupling reagent was achieved. The CIP-mediated reaction was also successfully applied for coupling of N-methylamino acid on solid support, demonstrating the first practical application of the solid-phase procedure for natural product synthesis
Dolastatin 15是Pettit et.在1989年。海兔素是从印度洋海兔中分离得到的一系列新颖的线性和环状多肽,其中海兔素15和海兔素10具有很强的活性和选择性,是海兔素中最重要的两个成员。因为在Pro残基处的活化是对异构化的抗性。将N,N-二甲基氨基酸掺入肽片段2中,因为CIP介导的活化预期对于溶液中的受阻偶联足够有效。用Pro、2-羟基异戊酸(Hiva)和Phe制备非肽片段。通过CIP介导的Phe和用作C2单元的Meldrum酯的偶联构建吡咯烷酮环。为了制备多肽片段,选择CIP介导的活化用于在固体支持物上偶联N-甲基氨基酸作为优选方案,以促进多拉司他汀15的实际合成。因此,在根据该方案合成多拉司他汀15之前,我们评估了CIP介导的活化在固体载体上制备含有N-甲基氨基酸的肽序列的效率。总之,使用CIP-HOAt作为有效偶联试剂,实现了利用片段和吡咯烷酮片段的单步缩合的会聚合成。CIP介导的反应也成功地应用于N-甲基氨基酸在固体载体上的偶联,证明了固相过程在天然产物合成中的首次实际应用

项目成果

期刊论文数量(7)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Kenichi Akaji: "Convergent Synthesis of Dolastatin 15 by Solid Phase Coupling of an N-Methylamino Acid"J. Org. Chem.. 64(2). 405-411 (1999)
Kenichi Akaji:“通过 N-甲基氨基酸固相偶联合成多拉司他汀 15”J。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Kenichi Akaji: "Efficient Synthesis of Peptaibol Using a Chloro Imidazolidium Coupling Reagent,CIP" Tetrahedron. 53. 567-584 (1997)
Kenichi Akaji:“使用氯咪唑啉偶联试剂,CIP 有效合成 Peptaibol”四面体。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Kenichi Akaji: "Convergent Synthesis of Dolastatin 15 by Solid Phase Coupling of N-Methylamino Acid"Peptide Chemistry,1998. 9-12 (1999)
Kenichi Akaji:“通过 N-甲基氨基酸固相偶联合成多拉司他汀 15”肽化学,1998 年。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Kenichi Akaji: "Convergent Synthesis of Dolastatin 15 by Solid Phase Coupling of N-Methylamino Acid"Peptide Chemistry, 1998. 9-12 (1999)
Kenichi Akaji:“通过 N-甲基氨基酸固相偶联合成多拉司他汀 15”肽化学,1998. 9-12 (1999)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

AKAJI Kenichi其他文献

AKAJI Kenichi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('AKAJI Kenichi', 18)}}的其他基金

Development of a novel persistent protease inhibitor containing D-amino acid
含D-氨基酸的新型持久性蛋白酶抑制剂的开发
  • 批准号:
    21590017
  • 财政年份:
    2009
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of SARS virus inhibitor using unusual amino acid-containing natural products as seeds
以含有罕见氨基酸的天然产物为种子开发SARS病毒抑制剂
  • 批准号:
    18590010
  • 财政年份:
    2006
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Combinatorial Synthesis of Transition State Mimetic Inhibitor Using Asymmetric Aldol, Reaction
使用不对称羟醛反应组合合成过渡态模拟抑制剂
  • 批准号:
    13672211
  • 财政年份:
    2001
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Intramolecularcyclization by solid-phase olefination and its application to combinatorial synthesis
固相烯化分子内环化及其在组合合成中的应用
  • 批准号:
    10557210
  • 财政年份:
    1998
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Convergent Synthesis of Anti-Cancer Alkaloid, Mirabazols, using a New Coupling Reagent
使用新型偶联剂聚合合成抗癌生物碱米拉巴唑
  • 批准号:
    08672459
  • 财政年份:
    1996
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of Low Molecular Weight HIV Protease Inhibitor for Oral Use
口服低分子量HIV蛋白酶抑制剂的研制
  • 批准号:
    07557141
  • 财政年份:
    1995
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)

相似海外基金

Food odor improvement by coupling reaction of fungal amine oxidase and bacterial aldehyde oxidase.
通过真菌胺氧化酶和细菌醛氧化酶的偶联反应改善食品气味。
  • 批准号:
    23K02002
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of innovative one-pot multi-step continuous cross-coupling reaction by dynamic control of catalyst structure
通过催化剂结构的动态控制开发创新的一锅多步连续交叉偶联反应
  • 批准号:
    20K21469
  • 财政年份:
    2020
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
SBIR Phase I: Development and commercialization of organic photocatalysts for light-driven C-N cross-coupling reaction
SBIR 第一阶段:用于光驱动 C-N 交叉偶联反应的有机光催化剂的开发和商业化
  • 批准号:
    1947053
  • 财政年份:
    2020
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Standard Grant
Extension and challenging application of rapidly processing alkyl coupling reaction on secondary alkyl carbons
仲烷基碳上快速烷基偶联反应的扩展和挑战性应用
  • 批准号:
    20K05501
  • 财政年份:
    2020
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of nickel-catalyzed cross-coupling reaction of aldehydes and alkenyl halides
镍催化醛与卤代烯交叉偶联反应的进展
  • 批准号:
    20H02737
  • 财政年份:
    2020
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Establishment of histamine poisoning prevention technology by coupling reaction of amine oxidase and aldehyde oxidase
胺氧化酶与醛氧化酶偶联反应预防组胺中毒技术的建立
  • 批准号:
    20K02338
  • 财政年份:
    2020
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Synthetic Study of Hasubanan-type Alkaloids based on Oxidative Phenolic Coupling Reaction
基于氧化酚偶联反应的哈苏巴南型生物碱的合成研究
  • 批准号:
    20K05488
  • 财政年份:
    2020
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Concise synthesis of nanographene by solid-state cross-coupling reaction
固相交叉偶联反应简洁合成纳米石墨烯
  • 批准号:
    19K15547
  • 财政年份:
    2019
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Visible-light photoredox catalyzed radical cation-radical coupling reaction
可见光光氧化还原催化自由基阳离子-自由基偶联反应
  • 批准号:
    19K15570
  • 财政年份:
    2019
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Efficient synthesis of functional molecules by multicomponent tandem coupling reaction and application for flow synthesis
多组分串联偶联反应高效合成功能分子及其在流动合成中的应用
  • 批准号:
    19K05479
  • 财政年份:
    2019
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了